/

In the Heart of Europe

Biomedica is part of the AddLife Group, a publicly traded parent company consisting of various subsidiaries in the Medtech and Labtech fields. AddLife strives to improve people’s lives by being a leading, value-creating player in Life Sciences.

Biomedica is part of the AddLife Group, a publicly traded parent company consisting of various subsidiaries in the Medtech and Labtech fields. AddLife strives to improve people’s lives by being a leading, value-creating player in Life Sciences.

We combine history with future, we speak many languages.

We are bringing out the best of different cultures… combining them.

We have been on the forefront as a distributor of Medical Devices, In Vitro Diagnostics, products for Life Sciences, Biomedica Immunoassays and Clinical IT for more than 40 years.

Our VISION: “We aim high for you – together, for better health”

Our MISSION: “Global Technology – Local Solutions”

We speak scientific and local languages. Inspired by the diversity of regional needs, we combine global technologies to deliver personalized solutions for healthcare, research and industry professionals.

The fundamental principles of our company philosophy with
respect to the following aspects are summarised as follows:

Group Management

Dr. Petra Wiedemann

CEO

Sales Director

Dr. Michaela Weblacher

Sales Director
Application & Technical Service

Area Managers

Karin Rappich
Managing Director
Bosnien-Herzegowina
Karin Rappich
Managing Director
Bulgarien
Karin Rappich
Managing Director
Kroatien
Ales Donat
Managing Director
Tschechien
Karoly Toth
Managing Director
Ungarn
Vida Peeva-Naumovska
Managing Director
Nordmazedonien
Norbert Krysiuk
Managing Director
Polen
Karin Rappich
Managing Director
Rumänien
Karin Rappich
Managing Director
Serbien
Karl Hirczy
Managing Director
Slowakei
Tadej Jesensek
Managing Director
Slowenien
Sheila Huber
Managing Director
Switzerland

History

  • Foundation of Biomedica in Vienna
  • First business br activities in Bulgaria, Poland, Romania and Hungary
  • Development and production of Biomedica Immunoassays (cardiological and osteology marker)
  • Establishment of independent, fully owned subsidiaries in CEE
  • ISO-Certification
  • Decentralization of local management in Poland, Czech Republic, Slovakia and Hungary
  • 12 subsidiaries established to cover the entire CEE region
  • Establishment of independent, fully owned subsidiary in Switzerland
  • AddLife AB acquired Biomedica November 2018